news CN Bio advances hepatotoxicity testing to reduce drug failures 19 February 2025 | By Drug Target Review CN Bio has developed an advanced hepatotoxicity testing solution to improve preclinical drug safety, providing more human-relevant insights and reducing the risk of drug failures due to liver damage.
whitepaper Beyond the Lab: Stem cell research 23 January 2025 | By Drug Target Review Download our latest report to discover how stem cell research is revolutionising treatments for chronic diseases, cancer and regenerative medicine.
news Improved understanding of the liver fibrosis process 18 March 2024 | By Drug Target Review Scientists have examined gene activity in mice models, noting important indicators of liver disease severity which may be used as therapeutic strategies.
news Novel bioactive dialysis system improves survival in pigs with acute liver failure 10 July 2020 | By Hannah Balfour (Drug Target Review) The bioreactor-based system incorporates liver cells to perform the detoxifying functions of the liver and was tested on pigs with acute liver failure.
news Anticancer drug as an alternative to liver transplant 17 August 2018 | By Drug Target Review Mouse models showed promise when an anticancer drug was used to treat liver failure, resulting in liver regeneration and preventing liver related death...